SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-045996
Filing Date
2021-09-01
Accepted
2021-08-31 20:51:38
Documents
13
Period of Report
2021-08-31
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea146750-8k_cmlifesci2.htm   iXBRL 8-K 43264
  Complete submission text file 0001213900-21-045996.txt   277746

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cmiiu-20210831.xsd EX-101.SCH 4235
3 XBRL DEFINITION FILE cmiiu-20210831_def.xml EX-101.DEF 28517
4 XBRL LABEL FILE cmiiu-20210831_lab.xml EX-101.LAB 38217
5 XBRL PRESENTATION FILE cmiiu-20210831_pre.xml EX-101.PRE 27131
6 EXTRACTED XBRL INSTANCE DOCUMENT ea146750-8k_cmlifesci2_htm.xml XML 7238
Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065
Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065 (212) 474 6724
CM Life Sciences II Inc. (Filer) CIK: 0001837412 (see all company filings)

IRS No.: 854298912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40090 | Film No.: 211228513
SIC: 8731 Services-Commercial Physical & Biological Research